Financial Summary (All financials)
| In millions, except per share items | Jun-30-16 | Jun-30-15 | Jun-30-14 | Jun-30-13 |
| Revenues | 0.2 | 0.0 | 0.0 | 0.3 |
| Revenue growth | 700.0% | 92.3% | -96.0% | |
| Cost of goods sold | 0.2 | 0.4 | 0.0 | 0.0 |
| Gross profit | 0.0 | -0.4 | 0.0 | 0.3 |
| Gross margin | 0.0% | -1500.0% | 100.0% | 100.0% |
| Research and development | 14.9 | 9.8 | 5.6 | 2.7 |
| General and administrative | 7.3 | 10.2 | 4.4 | 2.1 |
| EBIT | -22.2 | -20.1 | -10.0 | -4.5 |
| EBIT margin | -11112.0% | -80472.0% | -77153.8% | -1366.6% |
| Pre-tax income | -19.4 | -11.9 | -6.7 | -3.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -19.4 | -11.9 | -6.7 | -3.2 |
| Net margin | -9682.5% | -47428.0% | -51615.4% | -985.1% |
| |
| Diluted EPS | ($1.68) | ($2.27) | ($6.70) | ($3.62) |
| Shares outstanding (diluted) | 11.5 | 5.2 | 1.0 | 0.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|